STAAR Surgical Company (STAA)
NASDAQ: STAA · Real-Time Price · USD
18.16
+0.13 (0.72%)
Apr 28, 2025, 4:00 PM EDT - Market closed
STAAR Surgical Company Revenue
In the year 2024, STAAR Surgical Company had annual revenue of $313.90M, down -2.64%. STAAR Surgical Company had revenue of $48.95M in the quarter ending December 27, 2024, a decrease of -35.82%.
Revenue (ttm)
$313.90M
Revenue Growth
-2.64%
P/S Ratio
2.84
Revenue / Employee
$271,306
Employees
1,157
Market Cap
895.46M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 27, 2024 | 313.90M | -8.51M | -2.64% |
Dec 29, 2023 | 322.42M | 38.02M | 13.37% |
Dec 30, 2022 | 284.39M | 53.92M | 23.40% |
Dec 31, 2021 | 230.47M | 67.01M | 41.00% |
Jan 1, 2021 | 163.46M | 13.28M | 8.84% |
Jan 3, 2020 | Pro | Pro | Pro |
Dec 28, 2018 | Pro | Pro | Pro |
Dec 29, 2017 | Pro | Pro | Pro |
Dec 30, 2016 | Pro | Pro | Pro |
Jan 1, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
STAA News
- 4 days ago - STAAR Surgical Announces Changes to Board of Directors - Business Wire
- 5 days ago - STAAR Surgical to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025 - Business Wire
- 6 weeks ago - STAAR Surgical Announces Realignment of Leadership Structure - Business Wire
- 2 months ago - The Schall Law Firm Invites Shareholders With Losses In STAAR Surgical Company To Join A Securities Fraud Investigation - Accesswire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Encourages STAAR Surgical Company (STAA) Shareholders to Inquire about Securities Investigation - Accesswire
- 2 months ago - STAAR Surgical Announces Leadership Transition - Business Wire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating STAAR Surgical Company (STAA) And Encourages Shareholders to Connect - Accesswire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against STAAR Surgical Company (STAA) And Encourages Shareholders to Reach Out - Accesswire